National
Matthew Shepard book creates uproar
Laramie sheriff calls writer’s claims about 1998 murder ‘conspiracy theory BS’
A new book claims Matthew Shepard sold crystal meth and worked as an escort. His family said it won’t respond to ‘conspiracy theories.’
A newly published book that claims gay University of Wyoming student Matthew Shepard had a sexual relationship with his killer and his 1998 murder wasn’t a hate crime has triggered expressions of outrage by LGBT activists and fueled efforts by anti-gay groups to downplay the need for hate crimes laws.
“The Book of Matt: Hidden Truths About the Murder of Matthew Shepard,” written by gay journalist Stephen Jimenez and officially released on Tuesday, comes on the eve of the 15th anniversary of Shepard’s murder in Laramie, Wyo.
It also comes at a time when the “Laramie Project,” the internationally acclaimed play about the Shepard murder and its portrayal of the slaying as a hate crime, is about to open at the Ford’s Theater in Washington with a newly produced epilogue.
In addition, a documentary film called “Matt Shepard is a Friend of Mine,” directed by a filmmaker who was one of Shepard’s high school friends, is scheduled to premiere at the Washington National Cathedral on Oct. 4.
With the play and film exploring the Shepard murder as a hate crime that adversely impacted an entire community beyond the scope of an individual victim, the startling assertions made in Jimenez’s book have prompted at least one prominent gay commentator to reassess longstanding assumptions about the Shepard case.
“Events are more complicated than most politicians and activists want them to be,” said gay conservative commentator Andrew Sullivan. “No one should be afraid of the truth.”
Among the book’s claims is that Shepard, 21, knew and socialized with Aaron McKinney, also 21, one of two men convicted of his murder, at least a year before the crime. According to Jimenez’s stated findings in the book, Shepard and McKinney each used and sold crystal meth, both had been involved with an escort service in Denver and Laramie that arranged for them to have sex for money with men, they were seen at the same parties in Laramie, and the two occasionally had sex with each other.
Jimenez told the Blade he devoted more than 13 years of research and investigative reporting in preparation for his book, interviewing more than 100 people on the record, including a dozen people he identifies as friends of Shepard and more than a dozen friends of McKinney.
But some of the national LGBT advocacy groups have joined the Matthew Shepard Foundation, which was created by Shepard’s parents to combat anti-LGBT violence, in challenging the accuracy of the book and the credibility of its sources.
“Attempts now to rewrite the story of this hate crime appear to be based on untrustworthy sources, factual errors, rumors and innuendo rather than the actual evidence gathered by law enforcement and presented in a court of law,” a statement released by the Shepard Foundation says.
“We do not respond to innuendo, rumor or conspiracy theories,” the statement says. “Instead we remain committed to honoring Matthew’s memory, and refuse to be intimidated by those who seek to tarnish it.”
Albany County, Wyo., Sheriff David O’Malley, who served as Laramie police commander at the time of the murder, told the Blade on Tuesday that he believes the book “is full of lies” and described it as “conspiracy theory BS.”
Jimenez said he and others working with him have thoroughly and meticulously scrutinized and vetted the findings of his investigation, which he says included a careful reading of virtually all of the police and court records related to the case that initially had been sealed by a judge.
Laramie officials have said the records became available to the public in late 1999 shortly after the conclusion of the trial of McKinney, who was convicted of bludgeoning Shepard to death by repeatedly striking him in the head with the barrel of a .357 Magnum pistol while Shepard was tied to a fence at an isolated prairie just outside of town.
Co-defendant Russell Henderson confessed to having tied Shepard to the fence while accompanying McKinney on what he said began as a plan by McKinney to lure Shepard from a Laramie bar to rob him. Unlike McKinney, Henderson pleaded guilty to a murder charge rather than face a trial. Both men were sentenced to life in prison without the possibility of parole.
“I think the discovery of who Matthew Shepard was as a person and the complexity of who he was as a human being is really important,” Jimenez told the Blade.
“And so my reason for writing the book is to really say let’s understand what was really going on here,” he said. “If we’re serious about dealing with hate and violence in the culture, let’s understand what really happened here. What are the forces that came into play that created this grotesquely violent murder?”
Added Jimenez: “And certainly as I know now, the official story that these were two strangers that walked into a bar and targeted Matthew because he looked well-dressed and looked like he had money and appeared to be gay or that Matthew came on to them in the bar or that they lured him out of the bar because he was gay – those are simply not true.”
Jimenez was referring to the findings in the official police report that was based in part on a confession by McKinney to police at the time of his arrest three days after the murder. In his confession, McKinney said he and Henderson planned to rob Shepard, not to kill him. He said he lost control of his emotions and actions after Shepard allegedly groped him in the pickup truck that Henderson was driving after Shepard accepted McKinney’s invitation to drive him home from the Fireside bar on the night of Oct. 6, 1998.
McKinney’s lawyers, who attempted to invoke the so-called “gay panic” defense at McKinney’s trial, told the jury in his November 1999 closing argument that McKinney’s judgment was clouded that night by his consumption of alcohol and his use of and addiction to crystal meth amphetamine.
“Aaron McKinney is not a cold-blooded killer,” defense attorney Dion Custis said. “What happened is he hit him too many times” after the crystal meth consumption and Shepard’s alleged groping caused him to fly into an “uncontrollable rage.”
LGBT advocacy groups, noting that perpetrators of anti-gay hate crimes often use the gay panic defense as an alibi, said at the time that McKinney’s use of the gay panic defense confirmed their belief that McKinney’s motive was anti-gay hatred.
O’Malley said the police investigation found that McKinney had not been using crystal meth for several days and that investigators concluded that the murder “had nothing to do with drugs.” He said that the incident started as a robbery but investigators believe the brutality of the beating, in which McKinney crushed Shepard’s skull, involved a form of “overkill” that indicated the true motive was anti-gay animus.
Jimenez argues in his book that McKinney was suffering from the effects of his crystal meth use at the time of the attack but that some of his animus toward Shepard was based on alleged conflicts over a drug deal at a time when the two were working for rival drug suppliers. He bases this theory on information from both named and anonymous sources.
“It boggles the mind that this book flies in the face of all of the evidence related to the drug use,” said Cathy Renna, a former official with Gay & Lesbian Alliance Against Defamation (GLAAD), who attended the McKinney trial.
“Aaron McKinney has changed his story so many times it’s not even worth trying to keep count,” said Renna in referring to subsequent statements that McKinney has made to reporters in interviews from jail.
“But the one thing that Aaron McKinney has been clear about and has remained consistent to is that he didn’t know Matt beforehand.”
Renna and others questioning the reliability of Jimenez’s sources have cited a memo that ABC News correspondent Elizabeth Vargas mistakenly left at O’Malley’s residence in 2004, when she interviewed O’Malley, as confirmation that Jimenez reached his conclusions about the Shepard case before he began research for a controversial report on the ABC program 20/20. The memo, according to critics who have seen it, outlined the view the Shepard murder was not a hate crime along with some of the other revelations recounted in the Jimenez book.
Jimenez, however, told the Blade that the criticism is unfounded because his memo was based on more than two years of research that he already had conducted on the case long before he became involved in the 20/20 project.
He also disputes claims by critics that the 20/20 broadcast on the Shepard case in 2004 was based on unreliable sources.
“When I did the ABC News story every single note, every single interview transcript, everything we did was vetted by the top vice presidents and lawyers at ABC,” Jimenez said.
Concerning his book, Jimenez notes that the lead prosecutor in the Shepard murder case, Cal Rerucha, has stated on the record in his book that he agrees that the preponderance of evidence shows that drugs rather than anti-gay hate was the motive behind the murder of Matthew Shepard.
Regardless of whether the claims in Jimenez’s book are correct or not, some LGBT activists question the purpose of such a book, which they note has already been cited by right-wing anti-gay organizations to question the validity of hate crime legislation.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
A Wider Bridge to close
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
Rehoboth’s Blue Moon is for sale but owners aim to keep it in gay-friendly hands
Comings & Goings
Advocates say MTG bill threatens trans youth, families, and doctors
LGBTQ Democrats say they’re ready to fight to win in 2026
Brian Footer suspends campaign for Ward 1 D.C. Council seat
Far-right José Antonio Kast elected Chile’s next president
Lighting candles in a time of exhaustion
In real estate, trust the process
-
Politics3 days agoLGBTQ Democrats say they’re ready to fight to win in 2026
-
District of Columbia2 days ago
Brian Footer suspends campaign for Ward 1 D.C. Council seat
-
Chile5 days ago
Far-right José Antonio Kast elected Chile’s next president
-
Opinions3 days ago
Lighting candles in a time of exhaustion
